Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong · Delayed Price · Currency is HKD 36.96
+0.38 (1.04%)
Sep 11, 2026, 4:08 PM HKT
Sunshine Lake Pharma Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,479 | 1,487 | 1,481 | 1,674 | 923.54 | 1,131 |
Trading Asset Securities | 10.14 | 15.83 | 3.84 | - | 290 | - |
Cash & Short-Term Investments | 1,489 | 1,503 | 1,485 | 1,674 | 1,214 | 1,131 |
Cash Growth | 39.10% | 1.21% | -11.33% | 37.98% | 7.29% | -44.69% |
Accounts Receivable | 1,347 | 1,733 | 1,723 | 2,073 | 1,006 | 479.04 |
Other Receivables | 48.09 | 158.99 | 171.74 | 40.19 | 31.1 | 67.75 |
Receivables | 1,395 | 1,892 | 1,894 | 2,113 | 1,037 | 546.79 |
Inventory | 893.39 | 783.49 | 737.82 | 409.05 | 315.03 | 279.7 |
Restricted Cash | 75.62 | 25.5 | 435.62 | 1,567 | 76.78 | 91.99 |
Other Current Assets | 461.03 | 446.65 | 426.38 | 289.5 | 2,372 | 7.78 |
Total Current Assets | 4,413 | 4,651 | 4,979 | 6,053 | 5,014 | 2,057 |
Property, Plant & Equipment | 4,210 | 4,310 | 4,391 | 3,740 | 3,519 | 3,217 |
Long-Term Investments | 48.98 | 26.01 | 42.53 | 32.16 | - | 1,790 |
Goodwill | - | - | - | - | - | 75.9 |
Other Intangible Assets | 1,435 | 1,483 | 1,573 | 2,566 | 2,921 | 2,071 |
Long-Term Deferred Tax Assets | 342.55 | 278 | 283.49 | 237.69 | 140.61 | 65.32 |
Long-Term Deferred Charges | - | - | - | - | - | 1,201 |
Other Long-Term Assets | 1,222 | 1,245 | 662.29 | 115.38 | 295.76 | 64.83 |
Total Assets | 11,672 | 11,993 | 11,932 | 12,744 | 11,890 | 10,542 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,249 | 1,032 | 1,331 | 200.52 | 178.61 | 193.47 |
Accrued Expenses | 514.79 | 1,326 | 883.87 | 1,397 | 1,342 | 480.34 |
Current Portion of Long-Term Debt | 3,075 | 2,785 | 1,921 | 2,165 | 3,055 | 48.48 |
Current Portion of Leases | 429.78 | 460.25 | 316.31 | 154.44 | 75.44 | - |
Current Income Taxes Payable | 2.59 | 43.94 | 0.23 | 146.21 | 8.67 | 198.63 |
Current Unearned Revenue | 162.37 | 152.22 | 155.02 | 109.64 | 83.58 | 79.28 |
Other Current Liabilities | 361.06 | 238.28 | 206.9 | 158.48 | 197.86 | 237.87 |
Total Current Liabilities | 5,794 | 6,038 | 4,814 | 4,332 | 4,941 | 1,238 |
Long-Term Debt | 1,485 | 1,278 | 2,094 | 254 | 629.03 | 3,145 |
Long-Term Leases | 324.17 | 157.39 | 293.29 | 35.45 | 62.5 | - |
Long-Term Unearned Revenue | 197.08 | 181.98 | 262.95 | 187.15 | 187.49 | 137.73 |
Total Liabilities | 7,801 | 7,655 | 7,464 | 4,809 | 5,820 | 4,521 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 576.66 | 576.66 | 463.94 | 879.97 | 879.97 | 879.97 |
Retained Earnings | -1,248 | -644.48 | -332.49 | 4,387 | 2,395 | 2,318 |
Treasury Stock | -23.63 | -23.43 | -22.96 | - | - | - |
Comprehensive Income & Other | 4,559 | 4,436 | 235.65 | 2,668 | 2,610 | 2,610 |
Total Common Equity | 3,864 | 4,345 | 344.15 | 7,936 | 5,885 | 5,808 |
Minority Interest | 7.56 | -6.56 | 4,123 | - | 185.12 | 212.48 |
Shareholders' Equity | 3,871 | 4,338 | 4,468 | 7,936 | 6,070 | 6,021 |
Total Liabilities & Equity | 11,672 | 11,993 | 11,932 | 12,744 | 11,890 | 10,542 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5,313 | 4,680 | 4,624 | 2,609 | 3,822 | 3,194 |
Net Cash (Debt) | -3,824 | -3,177 | -3,140 | -934.92 | -2,608 | -2,062 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -7.03 | -6.38 | -7.12 | -4.03 | -11.24 | -8.89 |
Filing Date Shares Outstanding | 575.98 | 576.18 | 879.97 | 879.97 | 879.97 | 879.97 |
Total Common Shares Outstanding | 575.98 | 576.18 | 879.97 | 879.97 | 879.97 | 879.97 |
Working Capital | -1,381 | -1,387 | 164.51 | 1,721 | 73.24 | 819.31 |
Book Value Per Share | 6.71 | 7.54 | 0.39 | 9.02 | 6.69 | 6.60 |
Tangible Book Value | 2,428 | 2,862 | -1,229 | 5,370 | 2,964 | 3,662 |
Tangible Book Value Per Share | 4.22 | 4.97 | -1.40 | 6.10 | 3.37 | 4.16 |
Machinery | 4,996 | 4,798 | 4,409 | 3,448 | 3,021 | 2,680 |
Construction In Progress | 474.73 | 615.67 | 827.17 | 638.2 | 675.45 | 567.94 |